EAM
EPZM

Erste Asset Management’s Epizyme, Inc EPZM Stock Holding History

Erste Asset Management’s Portfolio EPZM Stock Details EPZM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-30,900
Closed -$372K – 519
2020
Q3 		$372K Sell
30,900
-44,300
-59% -$593K 0.01% 369
2020
Q2 		$1.22M Hold
75,200
– – 0.05% 280
2020
Q1 		$1.24M Sell
75,200
-200,000
-73% -$4.3M 0.07% 234
2019
Q4 		$6.23M Hold
275,200
– – 0.28% 91
2019
Q3 		$2.83M Hold
275,200
– – 0.15% 147
2019
Q2 		$3.43M Sell
275,200
-33,000
-11% -$425K 0.18% 130
2019
Q1 		$3.79M Buy
308,200
+40,000
+15% +$447K 0.21% 115
2018
Q4 		$1.58M Buy
+268,200
New +$2.05M 0.11% 182

Other funds holding EPZM

Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
RM
RP Management New York $139M AUM 37.98% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
KXA
KPCB XIII Associates Menlo Park, California $186M AUM 11.23% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return

Erste Asset Management's EPZM Position: Q4 2020 in Review

Erste Asset Management sold out of Epizyme, Inc (EPZM) in Q4 2020, closing a stake of 30,900 shares — an estimated $372K sold.

Erste Asset Management first reported a position in EPZM in Q4 2018 and held it in 8 quarters. The position peaked at $6.23M in Q4 2019. 138 funds tracked by Wall St. Rank hold EPZM as of Q4 2020.

  • Erste Asset Management reported no remaining Epizyme, Inc position as of Q4 2020 after selling out during the quarter.
  • Erste Asset Management sold 30,900 Epizyme, Inc shares in Q4 2020, an estimated $372K.
  • Erste Asset Management first reported a position in Epizyme, Inc in Q4 2018 and held it in 8 quarters.
  • Erste Asset Management's Epizyme, Inc position peaked at $6.23M in Q4 2019.
  • 138 funds tracked by Wall St. Rank held Epizyme, Inc as of Q4 2020.

Based on Erste Asset Management's 13F filing for Q4 2020, filed 25 Nov 2024.